Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Tonix Pharmaceuticals Holding Co announced plans to initiate a Phase 2 adaptive field study of the Tnx-4800 vaccine in the United States in the first half of 2027, aiming to prevent Lyme disease.

Tonix Pharmaceuticals Holding Co announced plans to initiate a Phase 2 adaptive field study of the Tnx-4800 vaccine in the United States in the first half of 2027, aiming to prevent Lyme disease.

老虎证券老虎证券2026/05/11 22:05
Show original
The implementation of the plan still requires a final agreement with the U.S. Food and Drug Administration.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!